1St patient recruited into CimetrA phase 3 clinical trial
Filed with ASX · · 4 pages · English
Story so far
Earlier from Argent Biopharma
- CannEpil available for free dispensing in ireland
- MGC pharma 2021 clinical trials program update
- CimetrA patent submitted to European IP office
- Further findings on ArtemiC as anti-inflammatory agent
- $1M order for ArtemiC Rescue from swiss PharmaCan
Later from Argent Biopharma
- Patent application lodged for novel drug delivery system
- MGC pharma executes US$24M US supply agreement
- Cimetra import approval granted for india
- Uk import permit granted for cannepil
- Artemic eu sale approval and clinical trial update
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma